Get Even More Visitors To Your Blog, Upgrade To A Business Listing >>

Opioid Crisis: USP’s Comments to the FDA

As government agencies consider solutions to the growing Opioid Crisis, the Food and Drug Administration (FDA) recently sought public comment about ways to best address this national emergency. USP was pleased to provide our perspective about how public standards might help support the agency’s efforts, and to report on our recent discussions with stakeholders and the standards being considered by USP’s Healthcare Quality Expert Committee.  

Global Health


This post first appeared on Quality Matters |, please read the originial post: here

Share the post

Opioid Crisis: USP’s Comments to the FDA

×

Subscribe to Quality Matters |

Get updates delivered right to your inbox!

Thank you for your subscription

×